Abstract
Transarterial chemo-embolization (TACE) is a valid and recommended treatment for patients with Barcelona Clinic Liver Cancer (BCLC) Stage B hepatocellular carcinoma (HCC). It is considered a safe procedure and the treatment-related mortality rate is less than 1%, mostly associated with acute liver failure, sepsis, renal failure or liver abscess. We reported a rare case of anaphylaxis and cardiac arrest during TACE, followed by successful cardiopulmonary resuscitation (CPR) and the management per anaphylaxis guideline, including epinephrine injection and glucagon infusion. The patient recovered well from this event and continued his treatment for HCC. The diagnosis, management and laboratory analysis of anaphylaxis is also reviewed in discussion. To our knowledge, it is the first case report of anaphylaxis-related cardiac arrest during TACE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Reviews and Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
